AZD9898 |
Catalog No.GC64919 |
AZD9898 est un inhibiteur de la leucotriène-C4 synthétase (LTC4S, glutathion S-transférase II) actif par voie orale, avec une CI50 de 0,28 nM.
Products are for research use only. Not for human use. We do not sell to patients.
Cas No.: 2042347-69-1
Sample solution is provided at 25 µL, 10mM.
AZD9898 is an orally active leukotriene-C4 synthetase (LTC4S, glutathione S-transferase II) inhibitor, with an IC50 of 0.28 nM. AZD9898 mitigates the GABA binding and hepatic toxicity signal. AZD9898 has the potential to treat asthma[1].
AZD9898 with the single dose of 100 mg/kg is well tolerated and no safety concerns are raised[1].
[1]. Munck Af RosenschÖld M, et al. Discovery of the Oral Leukotriene C4 Synthase Inhibitor (1S,2S)-2-({5-[(5-Chloro-2,4-difluorophenyl)(2-fluoro-2-methylpropyl)amino]-3-methoxypyrazin-2-yl}carbonyl)cyclopropanecarboxylic Acid (AZD9898) as a New Treatment for Asthma. J Med Chem. 2019 Aug 30.
Average Rating: 5
(Based on Reviews and 30 reference(s) in Google Scholar.)GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.
Required fields are marked with *